Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the enactment of “The Ensuring Fairness in Cost-Sharing Amounts Act.”

“Copay accumulator programs punish patients for accepting assistance from biopharmaceutical companies by preventing it from counting toward their out-of-pocket limits, forcing them to pay their deductible twice. Today’s enactment will protect those patients when a manufacturer helps to make their prescription more affordable.”

Buteas continued, “We are grateful to the legislative leaders who worked so hard to pass this important law – Senate President Nick Scutari, Senator Jon Bramnick, Assembly Majority Leader Lou Greenwald, Assemblyman Roy Freiman, and Assemblyman Sterley Stanley – and to Governor Murphy for signing it into law.  This makes healthcare more affordable for New Jerseyans, and is a win for patients throughout our state.”

# # #

About the HealthCare Institute of New Jersey (HINJ)

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) is a trade association that serves as the voice for our state’s leading research-based biopharmaceutical and medical technology companies. HINJ strives to raise awareness, understanding and public support for the state’s life sciences industry, expand patient access to the medical innovations our member companies produce and promote awareness of the life sciences’ economic impact in New Jersey.

To learn more, please visit www.hinj.org and follow us on X, Facebook and LinkedIn. For data on the life sciences’ impact on New Jersey’s economy, visit our By the Numbers page.